Categories: Health

Amwell to Participate in Upcoming Investor Conference

 | Source: Amwell

BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschhorn, CFO and COO, will participate in the TD Cowen 46th Annual Health Care Conference, taking place in Boston on March 3, including a fireside chat at 3:10 p.m. ET. An audio webcast of the fireside chat will be available at investors.amwell.com.

About Amwell

Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Contacts

Media:
press@amwell.com

Investors:
Asher Dewhurst
amwell@icrhealthcare.com 

GlobeNews Wire

Recent Posts

Helport AI Completes Key Consumer Finance AI Labor Workflow, Advancing Toward Scalable Replication

SAN DIEGO and SINGAPORE, July 20, 2026 (GLOBE NEWSWIRE) -- Helport AI Limited (NASDAQ: HPAI)…

25 minutes ago

Gatekeeper Unveils New Visual Identity to Reflect Its Natively Unified Architecture and Agentic Innovation

Now with full MCP support across every frontier LLM and a new Gatekeeper Chat experience,…

25 minutes ago

CMG Announces Date for First Quarter 2027 Results and Conference Call

CALGARY, Alberta, July 20, 2026 (GLOBE NEWSWIRE) -- Computer Modelling Group Ltd. (“CMG” or the…

25 minutes ago

VERAXA Biotech Announces Regulatory Progress with its BiTAC-TCE Development Plan

ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA), an emerging…

26 minutes ago

Harrow Highlights Growing Clinical Evidence Supporting IHEEZO and BYOOVIZ at ASRS 2026 Annual Meeting

July 20, 2026 07:00 ET  | Source: Harrow, Inc. NASHVILLE, Tenn., July 20, 2026 (GLOBE…

26 minutes ago

Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies

July 20, 2026 07:00 ET  | Source: Kamada Ltd. REHOVOT, Israel and HOBOKEN, N.J., July…

26 minutes ago